OSL ASX Chart
Snapshot
OncoSil Medical Limited (OSL) is an ASX-listed medical device company with a focus on localised treatments for patients with pancreatic and liver cancer. The company's lead product, OncoSil, is a medical device that delivers targeted radioactive isotope (Phosphorous-32) directly into a patient's pancreatic tumours via an endoscopic ultrasound. This treatment, known as brachytherapy, is intended to deliver more concentrated and localized radiation. Over the past year, the company has made significant progress in its operations, including the first commercial treatment of the OncoSil device in Europe.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +28.72% |
vs ASX 200 (1yr) | +30.25% |
Announcements
Corporate Overview
Corporate Details
Head Office | Macquarie Park NSW 2113 |
Website | www.oncosil.com |
Registry | BoardRoom |
Auditor | Crowe Sydney |
Date Listed | 15 Aug 2005 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
26/02/2025 | Report (Interim) |
29/08/2025 | Report (Prelim) |
29/09/2025 | Report (Prelim) |
29/09/2025 | Report (Annual) |
Former Company Names
- NeuroDiscovery Ltd (NDL), 31/05/2013.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
OSL directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of OSL directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Pengana Capital Group Ltd | 26/07/2024 | 385,714,286 | 10.19 |
Washington H. Soul Pattinson and Company Limited | 26/07/2024 | 385,714,286 | 10.19 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
26-07-24 | Washington H. Soul Pattinson and Company Limited | 385,714,286 | -- | 10.19 |
26-07-24 | Pengana Capital Group Ltd | 385,714,286 | -- | 10.19 |
08-05-24 | Sarah Cameron | 50,046,000 | 6.81 | 5.60 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
26-07-24 | Sarah Cameron | 184,776,034 | 5.60 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.004 | 28 June |
2023 | $0.012 | 30 June |
2022 | $0.04 | 30 June |
2021 | $0.053 | 30 June |
2020 | $0.115 | 30 June |
2019 | $0.053 | 28 June |
2018 | $0.23 | 29 June |
2017 | $0.097 | 30 June |
2016 | $0.14 | 30 June |
2015 | $0.10 | 30 June |
2014 | $0.10 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.